[Is it possible to have organized screening for ovarian cancer?].
Navone
R
R
Montanari
G
G
D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis; D018394:CA-125 Antigen / Q000097:blood; D002277:Carcinoma / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control / Q000556:secondary; D005260:Female; D006801:Humans; D008246:Lysophospholipids / Q000032:analysis; D008403:Mass Screening; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control; D010534:Peritoneal Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000556:secondary; D017698:Postmenopause; D015397:Program Evaluation; D016032:Randomized Controlled Trials as Topic; D014463:Ultrasonography
D014408:Biomarkers, Tumor; D018394:CA-125 Antigen; D008246:Lysophospholipids